Clinical Trial Update: Testosterone Replacement in Middle-Aged Hypogonadal Men With Dysthymia: Parallel Group, Double Blind Randomized Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized, double-blind trial evaluating testosterone replacement in middle-aged hypogonadal men with dysthymia; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Persistent Depressive Disorder

Drugs mentioned

• TESTOSTERONE (testosterone)

Snippet

Sponsor: Sheba Medical Center | Conditions: Dysthymic Disorder | Phase 4 | Status: UNKNOWN